|Articles|July 15, 2002
Microelectronic device continues to show promise
Fort Lauderdale, FL-A subretinal micro-photodiode-based silicon chip (Artificial Silicon Retina, ASR) implanted in patients with retinitis pigmentosa (RP) appears to be safe while showing continued improvement in both subjective and objective measures of visual function, said Alan Y. Chow, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology here.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5










































.png)


